Literature DB >> 15767229

Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy.

Alan J Zillich1, Joseph J Saseen, Renee M Dehart, Peter Dumo, Darren W Grabe, Cheryl Gilmartin, David M Hachey, Joanna Q Hudson, Maria C Pruchnicki, Melanie S Joy.   

Abstract

An increasing number of patients are developing chronic kidney disease (CKD). Appropriate care for patients with CKD must occur in the earliest stages, preferably before CKD progresses to more severe stages. Therefore, recognition and treatment of CKD and its associated complications must occur in primary care settings. Patients with CKD often have comorbid conditions such as diabetes mellitus, hypertension, and dyslipidemia, creating specific considerations when treating these diseases. Also, these patients have CKD-related conditions, including anemia and renal osteodystrophy, that are not traditionally evaluated and monitored by the primary care practitioner. Collectively, many opportunities exist for pharmacists who practice in the primary care setting to improve the care of patients with CKD.

Entities:  

Mesh:

Year:  2005        PMID: 15767229     DOI: 10.1592/phco.25.1.123.55628

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  10 in total

1.  Community pharmacist targeted screening for chronic kidney disease.

Authors:  Yazid N Al Hamarneh; Brenda Hemmelgarn; Craig Curtis; Carlee Balint; Charlotte A Jones; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-01

2.  Standards of clinical practice for renal pharmacists.

Authors:  Colette B Raymond; Lori D Wazny; Amy R Sood
Journal:  Can J Hosp Pharm       Date:  2013-11

3.  Evaluation of a training and communication-network nephrology program for community pharmacists.

Authors:  Lyne Lalonde; Michelle Normandeau; Diane Lamarre; Anne Lord; Djamal Berbiche; Louise Corneille; Louis Prud'homme; Marie-Claude Laliberté
Journal:  Pharm World Sci       Date:  2008-09-19

4.  Implementation of a Renal Replacement Therapy Simulation to Strengthen Essential Pharmacist Skills.

Authors:  Aimon C Miranda; Radha V Patel; Shyam R Gelot; Rowshan Chowdhury; Erini S Serag-Bolos
Journal:  Am J Pharm Educ       Date:  2019-03       Impact factor: 2.047

5.  Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study.

Authors:  Jacqueline Donovan; Yazid N Al Hamarneh; Beata Bajorek; John Papastergiou; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2020-02-13

Review 6.  New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.

Authors:  Wendy L St Peter; Lori D Wazny; Uptal D Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

7.  "The Disease Awareness Innovation Network" for chronic kidney disease identification in general practice.

Authors:  Francesco Pesce; Domenico Pasculli; Giuseppe Pasculli; Luca De Nicola; Mario Cozzolino; Antonio Granata; Loreto Gesualdo
Journal:  J Nephrol       Date:  2022-06-14       Impact factor: 4.393

Review 8.  Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.

Authors:  Gunar Stemer; Rosa Lemmens-Gruber
Journal:  BMC Nephrol       Date:  2011-07-22       Impact factor: 2.388

9.  Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study.

Authors:  Gunar Stemer; Sonja Zehetmayer; Rosa Lemmens-Gruber
Journal:  BMC Clin Pharmacol       Date:  2009-09-06

10.  Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations.

Authors:  Rebecca J Schmidt; Cheryl L Dalton
Journal:  Osteopath Med Prim Care       Date:  2007-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.